Deprenyl is metabolized to methamphetamine and amphetamine in man.

@article{Reynolds1978DeprenylIM,
  title={Deprenyl is metabolized to methamphetamine and amphetamine in man.},
  author={G. Reynolds and J. Elsworth and K. Blau and M. Sandler and A. Lees and G. Stern},
  journal={British journal of clinical pharmacology},
  year={1978},
  volume={6 6},
  pages={
          542-4
        }
}
Mechanisms of neurotransmitter release by amphetamines: A review
TLDR
Current issues on the two apparent primary mechanisms--the redistribution of catecholamines from synaptic vesicles to the cytosol, and induction of reverse transport of transmitter through plasma membrane uptake carriers are reviewed. Expand
Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy.
TLDR
This chiral analysis is the most useful technique to avoid the misinterpretation in the discrimination between clinical selegiline therapy and illicit MA use. Expand
Deprenyl: from chemical synthesis to neuroprotection.
During the last decades (-)-deprenyl has become the golden standard of MAO-B inhibitors. It possesses dopamine potentiating and antioxidant properties; however, its effects cannot be explained solelyExpand
The nitrosoamphetamine metabolite is accommodated in the active site of human hemoglobin: Spectroscopy and crystal structure.
TLDR
This work reports the first crystal structure of a wild-type heme protein adduct of any amphetamine metabolite and provides a framework for further studies of AmphNHOH/AmphNO interactions with Hb and Mb as viable processes that potentially contribute to the overall biological inorganic chemistry of amphetamine drugs. Expand
Pharmacokinetics of monoamine oxidase B inhibitors in Parkinson’s disease: current status
TLDR
In patients, concomitant inhibition of monoamine oxidase-B caused less increase of levodopa dosages over five years, and reduced need for L-dopa monotherapy, which reflects a disease-modifying effect. Expand
Possible involvement of PI 3 K / AKT / mTOR signaling pathway in the protective e ff ect of selegiline ( deprenyl ) against memory impairment following ischemia reperfusion in rat
Short-term cerebral ischemia led to memory dysfunction. There is a pressing need to introduce effective agents to reduce complications of the ischemia. Involvement of PI3K/AKT/mTOR signaling pathwayExpand
Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat
TLDR
It is concluded that selegiline, partially at least, through increases the expression of PI3K, AKT and mTOR as well as decreases the percent of dark neurons in the hippocampus could improve the memory impairment following the ischemia in rats. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 12 REFERENCES
Evidence that deprenyl, A type B monoamine oxidase inhibitor, is an indirectly acting sympathomimetic amine.
  • L. Simpson
  • Chemistry, Medicine
  • Biochemical pharmacology
  • 1978
TLDR
The ability of l-deprenyl to enter sympathetic neurons and evoke release of endogenous amines was not accompanied by a significant loss of tissue (heart) norepinephrine, suggesting that l-Deprenyl is an indirectly acting sympathomimetic amine whose responses are mediated by nore Pinephrine in postganglionic sympathetic neurons. Expand
DEPRENYL IN PARKINSON'S DISEASE
In a double-blind crossover trial, (-)-deprenyl, a fast-acting selective monoamine-oxidase-B inhibitor without a "cheese effect", was given to 41 patients with idiopathic Parkinson's disease who wereExpand
Dopamine is a monoamine oxidase B substrate in man
TLDR
It is demonstrated that, as far as DA oxidation is concerned, man may be different from rat: in two sites the authors have investigated, platelet and brain, DA is preferentially deaminated by an enzyme with the characteristics of MAOB. Expand
IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE A Long-term Study
TLDR
It is suggested that L-deprenil may act through inhibition of brain M.A.O. as well as by a psychostimulant effect similar to that of amphetamine which occurs through the release of dopamine to make more dopamine available at dopamine receptor sites. Expand
The metabolism of amphetamines in mammals.
  • J. Caldwell
  • Chemistry, Medicine
  • Drug metabolism reviews
  • 1976
Amphetamines in the treatment of Parkinson's disease.
TLDR
Amphetamines resulted in a significant improvement in disability from Parkinsonism, although the reduction in total disability, tremor, akinesia, and rigidity scores was slight and dextroamphetamine in lower dosage reduced disability by some 17 percent. Expand
Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics.
TLDR
Phenethylamines extracted from brain and liver of rats with phenylketonuria-like characteristics produced in vivo by inhibition of phenylalanine hydroxylase were investigated, and the content of phenethylamine was highest in the striatum. Expand
Effect of amphetamine on the pressor response to tyramine: Formation of p‐hydroxynorephedrine from amphetamine in man
TLDR
It was demonstrated that human sub;ects metabolize 8H‐amphetamine to p‐hydroxynorephedrine, an amine known to displace norepinephrine from the neuron terminal, which is a likely explanation for the diminished response to the indirectly acting amine. Expand
Comparative pharmacological analysis of the optical isomers of phenyl-isopropyl-methyl-propinylamine (E-250).
...
1
2
...